Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuroscience Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8592647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of beta-amyloid peptides with integrins in a human nerve cell line.

  1995cited by this paper
• Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide.

  1994cited by this paper
• Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.

  1993cited by this paper
• Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system

  1993cited by this paper
• Intraneuronal compartments of the amyloid precursor protein

  1993cited by this paper
• Molecular cloning of the cDNA for a human amyloid precursor protein homolog: evidence for a multigene family.

  1993cited by this paper
• Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.

  1992cited by this paper
• Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease.

  1992cited by this paper
• Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor

  1992cited by this paper
• Amyloid beta-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia.

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

  1989cited by this paper

• Glycosylated clusterin species facilitate Aβ toxicity in human neurons

  2022cites this paper
• Memory formation in old age requires GSK-3β

  2021cites this paper
• APP Maturation and Intracellular Localization Are Controlled by a Specific Inhibitor of 37/67 kDa Laminin-1 Receptor in Neuronal Cells

  2020cites this paper
• The Tyr216 phosphorylated form of GSK3β contributes to tau phosphorylation at PHF-1 epitope in response to Aβ in the nucleus of SH-SY5Y cells.

  2016cites this paper
• Synapse Assembly and Neurodevelopmental Disorders

  2015cites this paper
• The A&bgr;1-42 peptide regulates microtubule stability independently of tau

  2014cites this paper
• Tau-tubulin kinase

  2014cites this paper
• Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease.

  2012cites this paper
• Roles of glycogen synthase kinase 3 in Alzheimer's disease.

  2012cites this paper
• Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model

  2012cites this paper
• Axonal transport and neurodegenerative disease: can we see the elephant?

  2012cites this paper
• Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3

  2011cites this paper
• Beneficial Effects of Quetiapine in the APP/PS1 Transgenic Mice: Implications for Early Intervention for Alzheimer’s Disease

  2011cites this paper
• Bioinformatics Identification of Modules of Transcription Factor Binding Sites in Alzheimer's Disease-Related Genes by In Silico Promoter Analysis and Microarrays

  2011cites this paper
• The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases.

  2011cites this paper
• Increased Dickkopf‐1 expression in transgenic mouse models of neurodegenerative disease

  2010cites this paper
• Description and assessment of a model for GSK-3β database virtual screening

  2010cites this paper
• GSK3β in Ethanol Neurotoxicity

  2009cites this paper
• A functional mouse retroposed gene Rps23r1 reduces Alzheimer's beta-amyloid levels and tau phosphorylation.

  2009cites this paper
• Nuclear factor erythroid 2-related factor 2 protects against beta amyloid.

  2008cites this paper
• Novel GSK-3beta inhibitors from sequential virtual screening.

  2008cites this paper
• Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.

  2008cites this paper
• Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics

  2007cites this paper
• Wnt-Frizzled signalling and the many paths to neural development and adult brain homeostasis.

  2007cites this paper
• Antisense Inhibition at the β -Secretase-Site of APP Reduces Cerebral Amyloid and AChE Activity in Tg2576

  2007cites this paper
• Apoptotic action of E2F1 requires glycogen synthase kinase 3‐β activity in PC12 cells

  2007cites this paper
• Antisense inhibition at the beta-secretase-site of beta-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576.

  2007cites this paper
• In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.

  2006cites this paper
• Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance

  2006cites this paper
• GSK-3 is essential in the pathogenesis of Alzheimer's disease

  2006cites this paper
• Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3

  2005cites this paper
• GSK-3beta directly phosphorylates and activates MARK2/PAR-1.

  2005cites this paper
• Structure and function of amyloid in Alzheimer's disease.

  2004cites this paper
• Following the leader: fibrillization of alpha-synuclein and tau.

  2004cites this paper
• Molecular modelling approaches to the design of acetylcholinesterase inhibitors: new challenges for the treatment of Alzheimer's disease.

  2004cites this paper
• GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease

  2002cites this paper
• Glycogen synthase kinase 3: an emerging therapeutic target.

  2002cites this paper
• Role of GSK‐3β in Alzheimer's disease pathology

  2002cites this paper
• Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation*

  2002cites this paper
• Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells*

  2002cites this paper
• Different expression of glycogen synthase kinase-3β between young and old rat brains after transient middle cerebral artery occlusion

  2001cites this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cites this paper
• Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat.

  2000cites this paper
• A Unifying Hypothesis of Alzheimer's Disease. IV. Causation and Sequence of Events

  2000cites this paper
• Wnt signaling function in Alzheimer's disease.

  2000cites this paper
• Phosphorylation of tau protein by recombinant GSK‐3β: pronounced phosphorylation at select Ser/Thr‐Pro motifs but no phosphorylation at Ser262 in the repeat domain

  1999cites this paper
• Tau Protein in Normal and Alzheimer's Disease Brain: An Update

  1999cites this paper
• Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau.

  1998cites this paper
• Increased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cells.

  1998cites this paper
• Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA.

  1998cites this paper
• Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

  1997cites this paper
• Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures.

  1997cites this paper
• Effect of increased glycogen synthase kinase‐3 activity upon the maturation of the amyloid precursor protein in transfected cells

  1997cites this paper
• The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes.

  1997cites this paper
• Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II

  1996cites this paper
• Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.

  1996cites this paper
• Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.

  1996cites this paper
• Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.

  1995cites this paper